Wolverine Asset Management’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Wolverine Asset Management’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-520,910	Closed	-$5.65M	–	2168
2023 Q3	$5.65M	Buy	520,910 +36,583	+8%	+$392K	0.06%	292
2023 Q2	$5.16M	Buy	484,327 +359,694	+289%	+$3.78M	0.06%	288
2023 Q1	$1.3M	Sell	124,633 -3,415	-3%	-$35.4K	0.02%	621
2022 Q4	$1.32M	Buy	128,048 +87,778	+218%	+$891K	0.01%	673
2022 Q3	$404K	Buy	+40,270	New	+$403K	﹤0.01%	1091
2022 Q2	–	Sell	-242,892	Closed	-$2.4M	–	2578
2022 Q1	$2.4M	Buy	+242,892	New	+$2.4M	0.02%	461

Wolverine Asset Management's BIOS Position: Q4 2023 in Review

Wolverine Asset Management sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2023, closing a stake of 520,910 shares — an estimated $5.65M sold.

Wolverine Asset Management first reported a position in BIOS in Q1 2022 and held it in 6 quarters. The position peaked at $5.65M in Q3 2023. 0 funds tracked by Wall St. Rank hold BIOS as of Q4 2023.

Wolverine Asset Management reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Wolverine Asset Management sold 520,910 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $5.65M.
Wolverine Asset Management first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 6 quarters.
Wolverine Asset Management's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $5.65M in Q3 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on Wolverine Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.